BioMed Central and the University of Michigan are pleased to announce an agreement to publish a new open access journal, Clinical Diabetes and Endocrinology, which is now open for submissions and will begin publishing in the first quarter of 2015.
The journal is led by Editor-in-Chief, Meng H. Tan, Professor, Internal Medicine, in the Division of Metabolism, Endocrinology, and Diabetes, at the University of Michigan, with support from highly regarded Associate Editors and an international Editorial Board.
Clinical Diabetes and Endocrinology includes clinical, translational, healthcare, and epidemiological research surrounding diabetes and endocrine diseases. It will promote better care for patients by sharing with the community new knowledge, both research and clinical, on various aspects of endocrine disorders and their management. The audience for the new journal includes physicians, researchers, nurses, dietitians, pharmacists, podiatrists, psychologists, epidemiologists, exercise physiologists, and health care researchers.
Meng H. Tan says: "Clinical Diabetes and Endocrinology aims to promote better care for people with diabetes and endocrine diseases by sharing with their health professionals' new research and clinical knowledge on various aspects of their diseases. This collaborative academic-private initiative will make the new knowledge readily, freely and immediately accessible to these health professionals worldwide so it can have a global impact."
Peter Arvan, Division Chief, Metabolism, Endocrinology, and Diabetes, Director, Michigan Comprehensive Diabetes Center, says "The University of Michigan is proud to partner with BioMed Central for the launch of Clinical Diabetes and Endocrinology. We hope that this journal will have direct influence on the research and practice within the endocrine subspecialty. The diversity and remarkable credentials of this outstanding editorial board sends a signal that the journal stands for quality in publication to match the quality that we aspire to in our clinical practice."
Ted Hanss, Chief Information Officer, University of Michigan Medical School, says "We are delighted to be partnering with BioMed Central to launch this exciting new open access publication which will allow for critical medical knowledge to be disseminated without boundaries or restrictions worldwide."
Todd Hummel, Editorial Director, Clinical Medicine, at BioMed Central says: "We're very excited to launch Clinical Diabetes and Endocrinology in collaboration with the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan, and we look forward to working with Meng H. Tan and the entire Editorial Board on the journal."
Clinical Diabetes and Endocrinology is a peer-reviewed, online, open access journal that aims to promote better care for people with diabetes and endocrine disease. To achieve this, the journal publishes for health professionals new knowledge, both research and clinical, on various aspects of diabetes and endocrine diseases and their management.
BioMed Central is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.
Founded in 1850, the mission of the University of Michigan Medical School is to educate students, physicians, and biomedical scholars and to provide a spectrum of comprehensive knowledge, research, patient care and service of the highest quality to the people of the state of Michigan and beyond.
Founded in 1817, the mission of the University of Michigan is to serve the people of Michigan and the world through preeminence in creating, communicating, preserving and applying knowledge, art, and academic values, and in developing leaders and citizens who will challenge the present and enrich the future.
Clinical Diabetes and Endocrinology